TVTX NASDAQ
Travere Therapeutics, Inc.
1W: +1.4%
1M: +11.6%
3M: +47.2%
YTD: +13.2%
1Y: +154.8%
3Y: +171.5%
5Y: +144.9%
$44.43
-0.31 (-0.69%)
Weekly Expected Move ±6.1%
$37
$40
$43
$45
$48
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$536M
Revenue
+96.0% YoY
$-21M
Net Income
+90.6% YoY
$17M
Free Cash Flow
+108.6% YoY
79.0%
Gross Margin
-29.0%
Op. Margin
-29.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-24.6%
ROA-3.6%
ROIC-37.3%
Valuation
P/E-190.5
P/B41.3
EV/EBITDA75.9
Leverage
Debt/Equity2.86
Current Ratio2.74
Interest Cov.-3.6x
Quality Scores
Piotroski F6/9
Altman Z1.17
Beneish M-1.49